Skip Navigation

Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck

Brief Summary

Type:
Head and Neck Cancers

Study Type:
Treatment

Phase:
II/III

ClinicalTrials.gov Identifier:
NCT01810913

Study #:
13868

Start Date:
Sep 03, 2013

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT01810913

View Complete Trial Details & Eligibility at ClinicalTrials.gov